To confirm the
anti-allergic effects of the ethanolic extract of Angelica gigas (EAG), the levels of ear
erythema, ear weight, vascular leakage, heamatology,
tumor-necrosis factor-α,
interleukin-6 and
immunoglobulin E from mice sensitized with 2,4-dinitroflurorobenzene were examined. The results showed that EAG reduced ear
erythema and ear weight; we also found that
Evan's blue leakage decreased. Furthermore, the levels of
interleukin-6 and
immunoglobulin E in the serum were significantly inhibited. In RAW264.7 cells, EAG drastically inhibited the
mRNA levels of inducible
nitric oxide synthease,
tumor-necrosis factor-α and macrophage inflammatory protein-1β, suggesting that EAG may inhibit the release of pro-inflammatory
cytokines and acute neutrophilic
inflammation. Western blot analysis showed that EAG inhibited nuclear factor-κB- and extracelullar signal-regulated
protein kinase-dependent inflammatory pathways. Interestingly, EAG effectively inhibited the release of β-
hexosaminidase, a granule marker from mast cells. Taken together, our results demonstrate that EAG inhibits focal and systemic inflammatory and
allergic reactions, and holds great promise for the treatment of several inflammatory diseases.